Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Science 10 September 1976:
Vol. 193. no. 4257, pp. 1021 - 1023
DOI: 10.1126/science.1085035

Articles

Science, Vol 193, Issue 4257, 1021-1023
Copyright © 1976 by American Association for the Advancement of Science


articles

1,25-Dihydroxyvitamin D in biological fluids: a simplified and sensitive assay

JA Eisman, AJ Hamstra, BE Kream, and HF DeLuca

A competitive binding assay for 1,25-dihydroxyvitamin D [1,25-(OH2D] in plasma has been developed in which intestinal cytosol preparations from rachitic chicks are used as the binding protein. A new method of extraction and two new chromatographic procedures are used for this assay. The method is sensitive to as little as 10 picograms of 1,25-(OH)2D, and triplicate assays can be done on 5 milliliters of plasma. This assay shows that in the plasma of normal adult subjects there is a 1,25-(OH)2D concentration of 29 +/- 2 picograms per milliliter, while none can be detected in the plasma of nephrectomized subjects and end-stage renal failure patients.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Cloning of Human 25-Hydroxyvitamin D-1{alpha}-Hydroxylase and Mutations Causing Vitamin D-Dependent Rickets Type 1.
G. K. Fu, D. Lin, M. Y. H. Zhang, D. D. Bikle, C. H. L. Shackleton, W. L. Miller, and A. A. Portale (1997)
Mol. Endocrinol. 11, 1961-1970
   Abstract »    Full Text »    PDF »
Early Neonatal Hypocalcemia in Extremely Preterm Infants: High Incidence, Early Onset, and Refractoriness to Supraphysiologic Doses of Calcitriol.
P. S. Venkataraman, R. C. Tsang, J. J. Steichen, I. Grey, M. Neylan, and A. R. Fleischman (1986)
Arch Pediatr Adolesc Med 140, 1004-1008
   Abstract »    PDF »
Bone Disease in Alcohol Abuse.
D. D. BIKLE, H. K. GENANT, C. CANN, R. R. RECKER, B. P. HALLORAN, and G. J. STREWLER (1985)
Ann Intern Med 103, 42-48
   Abstract »    PDF »
Late Infantile Tetany and Secondary Hyperparathyroidism in Infants Fed Humanized Cow Milk Formula: Longitudinal Follow-up.
P. S. Venkataraman, R. C. Tsang, F. R. Greer, A. Noguchi, P. Laskarzewski, and J. J. Steichen (1985)
Arch Pediatr Adolesc Med 139, 664-668
   Abstract »    PDF »
The Development of Pseudohypoparathyroidism: Involvement of Progressively Increasing Serum Parathyroid Hormone Concentrations, Increased 1,25-Dihydroxyvitamin D Concentrations, and 'Migratory' Subcutaneous Calcifications.
R. C. Tsang, P. Venkataraman, M. Ho, J. J. Steichen, J. Whitsett, and F. Greer (1984)
Arch Pediatr Adolesc Med 138, 654-658
   Abstract »    PDF »
Secondary Hyperparathyroidism and Bone Disease in Infants Receiving Long-term Furosemide Therapy.
P. S. Venkataraman, B. K. Han, R. C. Tsang, and C. C. Daugherty (1983)
Arch Pediatr Adolesc Med 137, 1157-1161
   Abstract »    PDF »
Calcifediol (25-Hydroxyvitamin D3) in the Treatment of Uremic Bone Disease.
S. L. TEITELBAUM (1981)
Ann Intern Med 94, 404-405
   Abstract »    PDF »
Serum 1,25-Dihydroxyvitamin D Levels in Normal Children and in Vitamin D Disorders.
R. W. Chesney, J. F. Rosen, A. J. Hamstra, and H. F. DeLuca (1980)
Arch Pediatr Adolesc Med 134, 135-139
   Abstract »    PDF »
Evidence for extra-renal 1 alpha-hydroxylation of 25-hydroxyvitamin D3 in pregnancy.
T. Gray, G. Lester, and R. Lorenc (1979)
Science 204, 1311-1313
   Abstract »    PDF »
Adequate response of plasma 1,25-dihydroxyvitamin D to parturition in paretic (milk fever) dairy cows.
R. Horst, J. Eisman, N. Jorgensen, and H. DeLuca (1977)
Science 196, 662-663
   Abstract »    PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)